PS

Pinkiben Sandipbhai Mevada

Active Director Designated Partner DIN 09445659
DIN 09445659 First appointment Mar 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Pinkiben Sandipbhai Mevada

Data last updated:

Pinkiben Sandipbhai Mevada is a Designated Partner at Apirox Pharmaceuticals Llp (since 2022). The company operates in Pharma.

DIN 09445659
Primary Designation Designated Partner
Industry Pharma
First Appointment 07 Mar 2022
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner07 Mar 20222020Active

Board colleagues of Pinkiben Sandipbhai Mevada

Directorship timeline

Open interactive timeline →
Apirox Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Pinkiben Sandipbhai Mevada

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pinkiben Sandipbhai Mevada

Pinkiben Sandipbhai Mevada currently holds 1 directorship: Apirox Pharmaceuticals Llp (Designated Partner, since 07 Mar 2022).

Pinkiben Sandipbhai Mevada was first appointed on 07 Mar 2022 as Designated Partner at Apirox Pharmaceuticals Llp.

The current boards of Pinkiben Sandipbhai Mevada's companies include Bharatkumar Devjibhai Patel (Apirox Pharmaceuticals Llp), Dhruvesh Nagjibhai Ladumor (Apirox Pharmaceuticals Llp), Jayaben Maheshbhai Hadiya (Apirox Pharmaceuticals Llp), Jiteshkumar Rajabhai Ahir (Apirox Pharmaceuticals Llp), Mahesh Devjibhai Patel (Apirox Pharmaceuticals Llp), Nagjibhai Madhabhai Ladumor (Apirox Pharmaceuticals Llp), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available